Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.
Orlow I, Sadeghi KD, Edmiston SN, Kenney JM, Lezcano C, Wilmott JS, Cust AE, Scolyer RA, Mann GJ, Lee TK, Burke H, Jakrot V, Shang P, Ferguson PM, Boyce TW, Ko JS, Ngo P, Funchain P, Rees JR, O'Connell K, Hao H, Parrish E, Conway K, Googe PB, Ollila DW, Moschos SJ, Hernando E, Hanniford D, Argibay D, Amos CI, Lee JE, Osman I, Luo L, Kuan PF, Aurora A, Gould Rothberg BE, Bosenberg MW, Gerstenblith MR, Thompson C, Bogner PN, Gorlov IP, Holmen SL, Brunsgaard EK, Saenger YM, Shen R, Seshan V, Nagore E, Ernstoff MS, Busam KJ, Begg CB, Thomas NE, Berwick M; InterMEL Consortium. Orlow I, et al. Among authors: hanniford d. PLoS One. 2023 Apr 3;18(4):e0269324. doi: 10.1371/journal.pone.0269324. eCollection 2023. PLoS One. 2023. PMID: 37011054 Free PMC article.
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.
Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, Osman I, Hernando E. Segura MF, et al. Among authors: hanniford d. Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1814-9. doi: 10.1073/pnas.0808263106. Epub 2009 Feb 2. Proc Natl Acad Sci U S A. 2009. PMID: 19188590 Free PMC article.
Melanoma MicroRNA signature predicts post-recurrence survival.
Segura MF, Belitskaya-Lévy I, Rose AE, Zakrzewski J, Gaziel A, Hanniford D, Darvishian F, Berman RS, Shapiro RL, Pavlick AC, Osman I, Hernando E. Segura MF, et al. Among authors: hanniford d. Clin Cancer Res. 2010 Mar 1;16(5):1577-86. doi: 10.1158/1078-0432.CCR-09-2721. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179230 Free PMC article.
Clinical relevance of SKP2 alterations in metastatic melanoma.
Rose AE, Wang G, Hanniford D, Monni S, Tu T, Shapiro RL, Berman RS, Pavlick AC, Pagano M, Darvishian F, Mazumdar M, Hernando E, Osman I. Rose AE, et al. Among authors: hanniford d. Pigment Cell Melanoma Res. 2011 Feb;24(1):197-206. doi: 10.1111/j.1755-148X.2010.00784.x. Epub 2010 Oct 21. Pigment Cell Melanoma Res. 2011. PMID: 20883453 Free PMC article.
miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.
Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E, Rakus JF, Dankert JF, Shang S, Kerbel RS, Bhardwaj N, Shao Y, Darvishian F, Zavadil J, Erlebacher A, Mahal LK, Osman I, Hernando E. Gaziel-Sovran A, et al. Among authors: hanniford d. Cancer Cell. 2011 Jul 12;20(1):104-18. doi: 10.1016/j.ccr.2011.05.027. Cancer Cell. 2011. PMID: 21741600 Free PMC article.
Histology-specific microRNA alterations in melanoma.
Poliseno L, Haimovic A, Segura MF, Hanniford D, Christos PJ, Darvishian F, Wang J, Shapiro RL, Pavlick AC, Berman RS, Hernando E, Zavadil J, Osman I. Poliseno L, et al. Among authors: hanniford d. J Invest Dermatol. 2012 Jul;132(7):1860-8. doi: 10.1038/jid.2011.451. Epub 2012 May 3. J Invest Dermatol. 2012. PMID: 22551973 Free PMC article.
Revisiting determinants of prognosis in cutaneous melanoma.
Weiss SA, Hanniford D, Hernando E, Osman I. Weiss SA, et al. Among authors: hanniford d. Cancer. 2015 Dec 1;121(23):4108-23. doi: 10.1002/cncr.29634. Epub 2015 Aug 26. Cancer. 2015. PMID: 26308244 Free PMC article. Review.
BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.
Paoluzzi L, Hanniford D, Sokolova E, Osman I, Darvishian F, Wang J, Bradner JE, Hernando E. Paoluzzi L, et al. Among authors: hanniford d. Cancer Med. 2016 Jun;5(6):1183-93. doi: 10.1002/cam4.667. Epub 2016 May 11. Cancer Med. 2016. PMID: 27169980 Free PMC article.
MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway.
Koetz-Ploch L, Hanniford D, Dolgalev I, Sokolova E, Zhong J, Díaz-Martínez M, Bernstein E, Darvishian F, Flaherty KT, Chapman PB, Tawbi H, Hernando E. Koetz-Ploch L, et al. Among authors: hanniford d. Pigment Cell Melanoma Res. 2017 May;30(3):328-338. doi: 10.1111/pcmr.12578. Epub 2017 Apr 19. Pigment Cell Melanoma Res. 2017. PMID: 28140520 Free PMC article.
Functional analysis of RPS27 mutations and expression in melanoma.
Floristán A, Morales L, Hanniford D, Martinez C, Castellano-Sanz E, Dolgalev I, Ulloa-Morales A, Vega-Saenz de Miera E, Moran U, Darvishian F, Osman I, Kirchhoff T, Hernando E. Floristán A, et al. Among authors: hanniford d. Pigment Cell Melanoma Res. 2020 May;33(3):466-479. doi: 10.1111/pcmr.12841. Epub 2019 Nov 22. Pigment Cell Melanoma Res. 2020. PMID: 31663663 Free PMC article.
27 results